Dr. Keith Jerome, collaborators awarded amfAR grant for HIV cure research; NCI selects Hutch survivorship study among top 10 research highlights in 2016; and Dr. Nancy Davidson receives 2017 Women in Oncology Award
Tracking survivors long after treatment ends helps inform medical decisions for today’s patients and much more
Jan. 27, 2017
| By Rachel Tompa / Fred Hutch News Service
Every year since its inception in the early 1980s, the Fred Hutch Long-term Follow-up Program sends out a detailed questionnaire to every transplant survivor. The answers to these questions inform a host of research topics on the long-term effects of transplantation, from graft-vs.-host disease to cataracts, from secondary cancers to infertility and sexual dysfunction.
A roundup of some of our favorite 2016 stories on research at Fred Hutch
Dec. 30, 2016
| By Fred Hutch News Service staff
At Fred Hutch News Service, our writers witness daily the excitement of covering new developments in the science of cancer and the human immune system. As 2016 draws to a close, we asked them to sort through the stories about Fred Hutch research they had written this year, and offer our readers a selection of those they felt were most meaningful and important.
New study looks at how chemo affects childhood cancer survivors’ ability to have kids later in life
March 22, 2016
| By Diane Mapes / Fred Hutch News Service
A new Fred Hutch sheds light on the degree chemo can impact the fertility of childhood cancer survivors and suggests steps young cancer patients (and their parents) may want to take before they receive treatment. Lead author Dr. Eric Chow weighs in.
Dr. Peter Nelson principal researcher on prostate cancer 'Dream Team'; Dr. Kathi Malone honored by Komen Puget Sound; Dr. Eric Chow leads study of cardioprotective drug that addresses chemo concerns in children; and Dr. Linda Buck receives honorary doctorate from Harvard
May 28, 2015
| By Fred Hutch staff
Dr. Peter Nelson principal researcher on prostate cancer 'Dream Team'; Dr. Kathi Malone honored by Komen Puget Sound; Dr. Eric Chow leads study of cardioprotective drug that addresses chemo concerns in children; and Dr. Linda Buck receives honorary doctorate from Harvard.